Back to Rankings

TAK

Takeda PharmaceuticalC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
TAK vs peer average
50/100
TAK vs. peer average (C vs. C)
Grade spread
B 4 · C 3 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

NVS is the first available peer comparator.

Diversified, big-pharma peer with sizeable OTC/innovator balance; similar exposure to regulatory and emerging-market dynamics.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNVSNovartis
TAK
Takeda Pharmaceutical
NVS
Novartis
Grade
C
D
Momentum
29
28
Value
64
64
Sentiment
48
41
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs NVS

TAK / NVS
Grade Position
In line
TAK vs. peer average (C vs. C)
50/100
Momentum
29
TAK
Value
64
NVS
Sentiment
48
TAK

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TAK
1
NVS
NVS
D
40/100
+1
2
PFE
PFE
D
40/100
+1
3
SNY
SNY
C
60/100
Even
4
ARGX
argenx SE ADR
C
60/100
Even
5
HLN
Haleon PLC ADR
B
80/100
-1
NVS is the first peer returned for this comparison set.